Partnership Expansion KEW already enables molecular labs to adopt CANCERPLEX to expand precision medicine in local practice. There is a clear opportunity to scale this through a formal channel partner program with community and regional labs, CROs, and diagnostic networks, offering licensing, implementation, and joint marketing.

Platform Integration The Invitae collaboration and reliance on cloud services and open platforms indicate strong data interoperability. Sell integration services and APIs to embed CANCERPLEX into LIMS and EMR workflows, with seamless results delivery and secure data exchange.

Oncology Adoption KEW’s mission to guide cancer therapy through tumor genomics aligns with oncology clinics and tumor boards seeking CGP. Offer bundled CGP testing with companion diagnostics and access to targeted therapies, plus clinician education and decision-support tools to drive adoption in hospital systems.

Growth Signals Current revenue and funding positioning suggest capacity to scale. Target enterprise customers with scalable service levels, managed analytics, and dedicated customer success to support expanded panels, repeat testing, and multi-site deployments.

Geographic Reach Based in Cambridge with a lean team, KEW can leverage the local biotech ecosystem to partner with academic medical centers and regional hospitals across the U.S. Propose regional sales strategies, local lab partnerships, and flexible deployment options to accelerate adoption.